메뉴 건너뛰기




Volumn 8, Issue 5, 2013, Pages 871-876

Chimera of IL-2 linked to light chain of anti-IL-2 mAb mimics IL-2/anti-IL-2 mAb complexes both structurally and functionally

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; INTERLEUKIN 2; EPITOPE; IMMUNOGLOBULIN FC FRAGMENT; MONOCLONAL ANTIBODY; OVA-8; OVALBUMIN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

EID: 84878033053     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb3007242     Document Type: Article
Times cited : (16)

References (11)
  • 1
    • 33645465526 scopus 로고    scopus 로고
    • Selective stimulation of T cell subsets with antibody-cytokine immune complexes
    • Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D., and Sprent, J. (2006) Selective stimulation of T cell subsets with antibody-cytokine immune complexes Science 311, 1924-1927
    • (2006) Science , vol.311 , pp. 1924-1927
    • Boyman, O.1    Kovar, M.2    Rubinstein, M.P.3    Surh, C.D.4    Sprent, J.5
  • 2
    • 33745306112 scopus 로고    scopus 로고
    • IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb
    • Kamimura, D., Sawa, Y., Sato, M., Agung, E., Hirano, T., and Murakami, M. (2006) IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb J. Immunol. 177, 306-314 (Pubitemid 43939142)
    • (2006) Journal of Immunology , vol.177 , Issue.1 , pp. 306-314
    • Kamimura, D.1    Sawa, Y.2    Sato, M.3    Agung, E.4    Hirano, T.5    Murakami, M.6
  • 3
    • 80052038597 scopus 로고    scopus 로고
    • Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes exerts synergism with that of N -(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugate due to its low immunosuppressive activity
    • Tomala, J., Chmelova, H., Strohalm, J., Ulbrich, K., Sirova, M., Rihova, B., and Kovar, M. (2011) Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes exerts synergism with that of N -(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugate due to its low immunosuppressive activity Int. J. Cancer 129, 2002-2012
    • (2011) Int. J. Cancer , vol.129 , pp. 2002-2012
    • Tomala, J.1    Chmelova, H.2    Strohalm, J.3    Ulbrich, K.4    Sirova, M.5    Rihova, B.6    Kovar, M.7
  • 4
    • 65549091509 scopus 로고    scopus 로고
    • In vivo expansion of T reg cells with IL-2-mAb complexes: Induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression
    • Webster, K. E., Walters, S., Kohler, R. E., Mrkvan, T., Boyman, O., Surh, C. D., Grey, S. T., and Sprent, J. (2009) In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression J. Exp. Med. 206, 751-760
    • (2009) J. Exp. Med. , vol.206 , pp. 751-760
    • Webster, K.E.1    Walters, S.2    Kohler, R.E.3    Mrkvan, T.4    Boyman, O.5    Surh, C.D.6    Grey, S.T.7    Sprent, J.8
  • 5
    • 77954110406 scopus 로고    scopus 로고
    • In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy
    • Tomala, J., Chmelova, H., Mrkvan, T., Rihova, B., and Kovar, M. (2009) In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy J. Immunol. 183, 4904-4912
    • (2009) J. Immunol. , vol.183 , pp. 4904-4912
    • Tomala, J.1    Chmelova, H.2    Mrkvan, T.3    Rihova, B.4    Kovar, M.5
  • 6
    • 0030974616 scopus 로고    scopus 로고
    • Chimeric CLL-1 antibody fusion proteins containing granulocyte- macrophage colony-stimulating factor or interleukin-2 with specificity for B- cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties
    • Hornick, J. L., Khawli, L. A., Hu, P., Lynch, M., Anderson, P. M., and Epstein, A. L. (1997) Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties Blood 89, 4437-4447 (Pubitemid 27260254)
    • (1997) Blood , vol.89 , Issue.12 , pp. 4437-4447
    • Hornick, J.L.1    Khawli, L.A.2    Hu, P.3    Lynch, M.4    Anderson, P.M.5    Epstein, A.L.6
  • 7
    • 0032926185 scopus 로고    scopus 로고
    • Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors
    • Hornick, J. L., Khawli, L. A., Hu, P., Sharifi, J., Khanna, C., and Epstein, A. L. (1999) Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors Clin. Cancer Res. 5, 51-60 (Pubitemid 29045177)
    • (1999) Clinical Cancer Research , vol.5 , Issue.1 , pp. 51-60
    • Hornick, J.L.1    Khawli, L.A.2    Hu, P.3    Sharifi, J.4    Khanna, C.5    Epstein, A.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.